BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hypothalamus
,
Alcohol
,
Clofibrate
,
rs2300478
,
PRKCA
,
Fatty acid metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
STAT3;jsessionid=216B062F2EC8727C062289286C0293DA
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Pericardium
Neutrophil of bone marrow
Leukocyte (polymorphonuclear) of peripheral blood
Peritoneum
Skeletal muscle psoas
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Discovery of STAT3 Inhibitors: Recent Advances and Future Perspectives.
STAT3 signaling in B cells controls germinal center zone organization and recycling.
circPTPN22 attenuates immune microenvironment of pancreatic cancer via STAT3 acetylation.
STAT3 signaling in pancreatic ductal adenocarcinoma: a candidate therapeutic target.
Perspective: mitochondrial STAT3 in cardioprotection.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for STAT3;jsessionid=216B062F2EC8727C062289286C0293DA
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ